Biallelic missense mutations in MARS are responsible for rare but severe cases of pulmonary alveolar proteinosis (PAP) prevalent on the island of La R eunion. MARS encodes cytosolic methionyl-tRNA synthetase (MetRS), an essential translation factor. The multisystemic effects observed in patients with this form of PAP are consistent with a loss-of-function defect in an ubiquitously expressed enzyme. The pathophysiological mechanisms involved in MARS-related PAP are currently unknown. In this work, we analyzed the effect of the PAP-related mutations in MARS on the thermal stability and on the catalytic parameters of the MetRS mutants, relative to wild-type. The effect of these mutations on the structural integrity of the enzyme as a member of the cytosolic multisynthetase complex was also investigated. Our results establish that the PAP-related substitutions in MetRS impact the tRNA Met -aminoacylation reaction especially at the level of methionine recognition, and suggest a direct link between the loss of activity of the enzyme and the pathological disorders in PAP.
Introduction
Pulmonary alveolar proteinosis (PAP) is a rare cause of chronic lung disease characterized by the alveolar accumulation of surfactant, a lipoproteinaceous material [1] , leading to hypoxemic respiratory failure. The size of the pool of surfactant is tightly regulated at the levels of its synthesis and degradation. PAP may be primary or secondary to various diseases, including immune deficiencies, metabolic disorders, and infections. Primary PAP include autoimmune forms related to anti-GM-CSF (granulocyte-macrophage colonystimulating factor) autoantibodies, representing the main cause in adults, and genetic forms, with isolated mutations in genes encoding the a and b chains of the GM-CSF receptor. When GM-CSF signaling is deficient, surfactant catabolism is impaired and it accumulates in the alveoli, leading to a reduced oxygenation capacity [1] . Recently, we identified mutations in the MARS gene by exome sequencing in a specific type of PAP prevalent on La R eunion and the nearby islands, and also in three patients originated from other geographic areas [2] . This disorder differs from other forms of PAP as it usually displays an early onset and a severe prognosis with frequent progression to pulmonary fibrosis (70%), and also associates a liver involvement (90%), a systemic inflammation (90%), and failure to thrive (90%) [3] .
MARS encodes the cytosolic methionyl-tRNA synthetase (MetRS) that belongs to the class 1 family of aminoacyl-tRNA synthetases (AARSs). These enzymes play a critical role in protein biosynthesis by charging tRNAs with their cognate amino acids. MetRS is also, with other AARSs, a component of a cytosolic multiprotein complex (the MSC; Multiaminoacyl-tRNA Synthetase Complex) with multiple roles described in immune response, inflammation, tumorigenesis, angiogenesis, and neuronal homeostasis [4, 5] . MetRS is ubiquitously expressed, consistent with the multisystemic phenotype observed in patients with PAP. However, pathophysiological mechanisms of this disease are still unknown.
The four PAP-related mutations identified in the MARS gene [2] correspond to amino acid substitutions within the catalytic domain of MetRS (Fig. 1 [6, 7] , and in one case report with a multisystemic phenotype that resembled MARS-related PAP [8] . The effect of these mutations on the catalytic activity of MetRS is generally unknown, and the putative direct functional correlation between a specific mutation and a given disease is also unknown. Deciphering the molecular mechanisms of MARS-related PAP is essential to understand the pathophysiology of this specific disease. Previous experiments showed that introduction of these mutations into yeast MetRS leads to a growth retardation phenotype that could be alleviated by methionine supplementation in the culture medium [2] . These data suggested that mutations identified in PAP could be related to a deficiency of MetRS activity that could affect the functioning of alveolar macrophages which are responsible for surfactant homeostasis.
The human MetRS is a monomeric class I aminoacyltRNA synthetase consisting of 900 amino acid residues (Fig. 1) . Methionylation of tRNA Met is a two-step mechanism. Methionine is first activated by MetRS with ATP to form methionyl-adenylate, which is then transferred to the 3 0 -end of tRNA [9] . The conserved catalytic core of the enzyme is made of a Rossmann-fold catalytic domain, organized around a parallel b-sheet, and of a a-helical tRNA anticodon-binding domain [10, 11] . A connective polypeptide (CP) is inserted into the nucleotide-binding fold. In Escherichia coli MetRS, the CP contains one zinc ion that contributes to the stabilization of the transition state of the methionine activation reaction [12] . In human, a protein-binding domain (PBD) is appended at the N-terminus of the core enzyme, and an additional tRNA-binding domain (tRBD) at the C-terminus. The PBD interacts with the p18 protein [13] and associates MetRS into subcomplex I of the multisynthetase complex (MSC), which also contains isoleucyland leucyl-tRNA synthetase, as well as the bifunctional glutamyl-prolyl-tRNA synthetase [14] . The tRBD provides the core enzyme with potent tRNA-binding properties [15] . The crystal structure of the core domain of human cytosolic MetRS has been recently solved (PDB 5GL7 and 5GOY). The CP inserted between the two halves of the Rossmann fold contains two zinc ions. Removal of zinc leads to the inactivation of human MetRS [16] . The mutation p.Ala393Thr is adjacent to the Cys 392 residue, one of the four Cys residues that build the first zinc-binding site.
The PAP-related mutations are localized in the catalytic domain of MetRS, in the vicinity of the HLGN and KFSKS sequence motifs that play a key role in catalysis [9] , surrounding the catalytic core of the enzyme. However, with the exception of Tyr 344 , the residues substituted in PAP are not conserved in evolution (Fig. 1) . In this study, the impact of the four mutations on the association of MetRS in the MSC, on its thermal stability, or on its kinetic parameters in the tRNA-aminoacylation reaction was analyzed. Kinetic data suggest that methionine availability plays a major role in PAP.
Results
The PAP-related MetRS mutants retain the capacity to associate within the MSC T and S 567 L) was expressed in HeLa cells with a C-terminally appended TAP tag. After the first step of TAP purification on an IgG column, MetRS and associated proteins were recovered by TEV digestion. As shown in Fig. 2A , the three polypeptides of high molecular mass corresponding to GluProRS (171 kDa), IleRS (145 kDa), and LeuRS (134 kDa) were clearly visible in the purified fraction, together with MetRS-cTAP. To remove the contaminating IgGs, the second step of TAP purification was conducted on a calmodulin column. The composition of the purified fractions was analyzed by Western blot with a mix of anti-GluProRS, anti-IleRS, anti-LeuRS, and anti-GlnRS antibodies. As shown in ). The CAT domain is in light green, the CP in dark green, the b-strands from the Rossmann fold in yellow, the ABD domain in blue, the methionine substrate is in red sticks, the two zinc ions in orange.
two mutations identified in the double mutant (A 393 T or S 567 L) were constructed in the pET28b plasmid, expressed in E. coli, and purified to homogeneity (Fig. 3) . The activity of enzyme preparations was assessed by initial velocity measurements in the tRNA Met -aminoacylation reaction under the standard conditions indicated in Materials and Methods. As shown in Fig. 3 , all the mutants remained active, but the activity of mutant D 605 V, and especially of mutants Y 344 C, S 567 L, and A 393 T/S 567 L, was significantly reduced relative to wild-type.
Effect of the PAP-related mutations on the thermal stability of MetRS
To assess the consequences of the PAP-related mutations on the folding and stability of the MetRS variants, we measured the thermal stability of the mutants relative to wild-type (Fig. 4) 
Discussion
In this study, we analyzed the effect of the PAPrelated mutations in MetRS on its association within The three PAP-related mutations also have a noticeable effect on the rate of the aminoacylation reaction with a k cat reduced 5-to 6-fold, relative to WT. Globally, all the MetRS mutants identified in patients with PAP are likely to be more sensitive to the availability of methionine, relative to WT, in agreement with previous studies showing that the growth retardation phenotype observed after introduction of these mutations in yeast MetRS can be rescued by methionine supplementation in the culture medium [2] . Altogether, these data provide a rational basis to account for the pathophysiological mechanisms uncovered in MARS-related PAP.
Here, we clearly showed that the mutations recovered in MetRS from the patients with this specific form of PAP prevalent on the island of La R eunion affect the essential aminoacylation function of MetRS at the level of methionine recognition. Although a loss-of-function defect was also postulated for MARS with the mutations F 370 L and I 523 T associated with patients displaying multisystemic disorders [8] , or with the mutation R 618 C associated with Charcot-Marie-Tooth disease [6] , it is the first time that a loss-of-function defect can be attributed to a specific step in the aminoacylation reaction, namely, methionine recognition and its transfer to the tRNA molecule. Because MetRS is ubiquitous to all cell types, a defect of the primary aminoacylation function of MetRS, leading to a reduced translation efficiency, is likely to be responsible for the multisystemic phenotypes observed in patients with PAP which associates a liver involvement, a systemic inflammation, and failure to thrive [3] . The pulmonary involvement being the major prognostic factor in PAP, it remains to be deciphered why perturbation of methionine recognition by MetRS is the basis of this specific disease.
Methionine is an essential amino acid, which is required for protein and polyamine synthesis, and for methylation reactions. Methionine is also sensitive to oxidation, and can be easily modified into methionine sulfoxide [17] . This observation raises the possibility that the concentration of bona fide methionine could be more limiting in the lungs, where oxygen pressure is especially elevated, as compared to other tissues. If methionine becomes the limiting substrate in the tRNA Met -aminoacylation reaction catalyzed by the PAP-related MetRS variants, then, giving an excess of methionine to these patients could be a means to restore a level of activity close to WT. Increasing the dose of methionine in nutrients, which is the precursor of homocysteine, should be manipulated carefully, as it is toxic in humans, leading to vascular dysfunctions and cardiovascular diseases [18] . Nevertheless, as there is currently no curative treatment for this severe disorder, a clinical trial of methionine supplementation could be considered in patients with MARS-related PAP, with a close monitoring of methionine and homocysteine plasmatic concentrations.
Materials and methods

Expression of MetRS in E. coli
The catalytic core of human MetRS was expressed in E. coli BL21(DE3) transformed with the plasmid pET/ MHsΔC described previously [15] . Briefly, the protein carrying a N-terminal His tag was purified on a NiNTA Superflow matrix (QIAGEN, Courtaboeuf, France) followed by anion-exchange chromatography on a Mono Q HR 5/5 column (GE Healthcare, Velizy-Villacoublay, France). The protein was stored at À20°C in 20 mM TrisHCl pH 7.0, 50 mM NaCl, 2 mM DTT, and 55% glycerol. Protein concentrations were determined using an absorption coefficient of 1.42 A 280 unitsÁmg À1 Ácm 2 .
Site-directed mutagenesis were expressed and purified as described above for wild-type.
Thermal inactivation
Purified wild-type or mutant MetRS was incubated at a protein concentration of 0.1 lM (13.6 lgÁmL
À1
) in 10 mM Tris-HCl (pH 7.5), 10 mM 2-mercaptoethanol, and 4 mgÁmL À1 bovine serum albumin, at varying temperatures.
After 60 min of incubation, samples were withdrawn from the incubation mixture and placed on ice. The residual MetRS activity in the samples was determined by the tRNA Met -aminoacylation assay.
Aminoacylation assay
Initial rates of tRNA aminoacylation were measured at 25°C in 0.1 mL of 20 mM Imidazole-HCl (pH 7.5), 150 mM KCl, 0.5 mM DTT, 13 mM MgCl 2 , 3 mM ATP, 180 lM 14 C-labeled methionine (NEN; 54 CiÁmol À1 ), and saturating amounts of tRNA, except otherwise stated, as previously described [15] . Total brewer's yeast tRNA (Roche, methionine acceptance of 9 pmol per A 260 ) or homogeneous rabbit elongator tRNA Met purified from an E. coli overproducing strain as previously described [19] (methionine acceptance of 1215 pmol per A 260 ) was used as tRNA substrates. The incubation mixture contained catalytic amounts (1-10 nM) of enzymes appropriately diluted in 10 mM Tris-HCl (pH 7.5), 10 mM 2-mercaptoethanol, containing bovine serum albumin at 4 mgÁmL 
TAP tag
The nucleotide sequences encoding full-length wild-type human MetRS, or the full-length mutants MetRS Y344C , MetRS D605V , and MetRS A393T/S567L were reconstituted into pSG5-CTAP, as described previously [14] . The encoded proteins contain a TAP tag appended to their C-terminal extremity, made of calmodulin-binding peptide and protein A, with a TEV cleavage site just in between. HeLa cells grown in DMEM medium (Life Technologies, Courtaboeuf, France) supplemented with 10% fetal calf serum were transfected with Effectene (QIAGEN). Forty-eighty hours after transfection, TAP-tagged MetRS was purified by the TAP procedure described previously [14] . Briefly, TAP-tagged proteins were bound on immobilized IgGs, released by TEV protease digestion, adsorbed on a calmodulin column in the presence of Ca 2+ , and eluted by the addition of EGTA. Purified proteins were analyzed by SDS-PAGE and visualized by staining with Coomassie Blue R250, or by immunodetection with antibodies.
